Biomolecules touch nearly every major industry, from the enzymes that clarify your beer to the antibodies that detect cancer biomarkers. The global market for industrial enzymes alone was valued at roughly $8 billion in 2025 and is projected to reach $12.4 billion by 2033, growing at 5.6% annually. That figure only captures one category of biomolecule. When you add therapeutic proteins, agricultural compounds, and diagnostic tools, the economic footprint is far larger.
Food and Beverage Production
The food industry is one of the heaviest users of biomolecules, relying on dozens of specialized enzymes at nearly every stage of production. In dairy, rennet (a mixture of the enzymes chymosin and pepsin) has been used in cheesemaking since ancient times, coagulating milk proteins to form curds. Lipases break down milk fats to enhance cheese flavor, reduce bitterness, and prevent rancidity. Lactase splits lactose into simpler sugars, making lactose-free dairy products possible for the roughly 70% of the global population with some degree of lactose intolerance. Other enzymes speed up cheese ripening and produce low-calorie sweeteners like D-tagatose from milk sugars.
Baking depends on a different toolkit. Amylases convert starch into sugars that feed yeast, controlling bread volume and crumb structure. Glucose oxidase strengthens dough by cross-linking proteins. Xylanase improves the texture, shelf life, and volume of bread loaves. In brewing, enzymes remove oxygen from beer to extend shelf life, prevent off-flavors, and break down protein-polyphenol complexes that cause haziness, producing a clearer, more stable product.
Beyond traditional enzymes, precision fermentation is opening new territory. Companies are now using engineered microorganisms to produce specific food proteins, like ovalbumin (the main protein in egg whites), at concentrations exceeding 100 grams per liter in optimized systems. This approach can replicate animal-derived ingredients without the animal.
Pharmaceuticals and Biologics
Biomolecules are the foundation of an entire class of medicines called biologics. Monoclonal antibodies, which are lab-engineered versions of immune system proteins, now treat cancers, autoimmune diseases, and inflammatory conditions. The FDA maintains a dedicated Therapeutic Biologics Program focused on these molecules, with active development areas including bispecific antibodies (engineered to bind two different targets simultaneously) and antibody-drug conjugates that deliver chemotherapy directly to tumor cells.
Recombinant proteins, produced by inserting human genes into bacteria or yeast, give us insulin for diabetes, clotting factors for hemophilia, and growth hormones for deficiency disorders. Nucleic acid therapies, including mRNA vaccines, represent a newer frontier where the biomolecule itself carries genetic instructions that tell your cells to produce a therapeutic protein. Each of these categories depends on manufacturing biomolecules at high purity and industrial scale.
Medical Diagnostics and Biosensors
The devices that monitor your health rely heavily on biomolecules as sensing elements. Continuous glucose monitors, for example, use the enzyme glucose oxidase. When glucose in your blood or interstitial fluid contacts this enzyme, it triggers a chemical reaction that generates a measurable electrical signal proportional to your glucose level. Modern versions of these sensors can detect glucose at concentrations as low as 0.001 mg/mL.
Antibody-based biosensors, called immunosensors, detect specific molecules by exploiting the lock-and-key fit between an antibody and its target. These are used in point-of-care devices to identify cancer biomarkers like interleukin-10 (a lung cancer indicator), monitor immune responses by detecting interferon-gamma, and even count tumor cells. Other enzymes used in diagnostic sensors include lactate oxidase (for measuring lactic acid during exercise or critical illness) and horseradish peroxidase (for detecting hydrogen peroxide, a marker of cellular stress).
Agriculture and Crop Protection
Agriculture increasingly uses biomolecules as alternatives to synthetic chemical pesticides and fertilizers. The most widely adopted bioinsecticide comes from the bacterium Bacillus thuringiensis, which produces crystal proteins that are toxic to specific insect pests but harmless to mammals. These proteins are so effective that the genes encoding them have been engineered directly into crops like Bt corn and Bt cotton.
On the fertilizer side, nitrogen-fixing bacteria like Rhizobium produce the enzyme nitrogenase, which converts atmospheric nitrogen into a form plants can absorb. Other soil bacteria produce organic acids (gluconic and keto-gluconic acids) that dissolve bound phosphorus in the soil, making it available to plant roots without synthetic phosphate fertilizers. For weed control, certain fungal metabolites can completely inhibit the germination of parasitic weed seeds, offering targeted bioherbicide options.
Energy and Biofuels
Converting plant material into fuel is fundamentally a biomolecule challenge. Second-generation biofuels aim to use agricultural waste, wood chips, and grasses rather than food crops, but the tough, fibrous structure of these materials resists breakdown. The process requires enzymatic cocktails, mixtures of cellulases and related enzymes, that disassemble the long-chain sugars locked inside plant cell walls into simple sugars like glucose, xylose, and arabinose. Yeast or bacteria then ferment those sugars into ethanol, butanol, or other fuel compounds.
The resulting biofuels can be blended directly with gasoline, converted into gasoline additives, or processed into biodiesel for diesel engines. The main bottleneck remains efficiency: plant fiber is naturally resistant to enzymatic breakdown, so developing more powerful enzyme cocktails and better pre-treatment methods is where much of the industry’s effort is focused.
Cosmetics and Personal Care
The skincare industry has embraced bioactive peptides as functional ingredients. At least 102 commercially available cosmetic peptides have been identified, many of them inspired by molecules naturally found in human skin. A major category is matrikines, short peptide fragments derived from the structural proteins that make up your skin’s support network. These peptides signal skin cells to ramp up production of collagen and hyaluronic acid, the molecules responsible for firmness and hydration.
Other cosmetic peptides work by inhibiting enzymes that break down collagen, modulating pigmentation to even skin tone, acting as antioxidants, or interfering with neurotransmitter signaling to reduce the appearance of expression lines (a mechanism similar to how certain injectable treatments work, but applied topically). The range of claimed activities also extends to supporting the skin microbiome and carrying trace minerals into the skin.
Environmental Cleanup
Bioremediation uses microbial enzymes to break down pollutants that would otherwise persist in soil and water for decades. This approach is considered more cost-effective and environmentally friendly than chemical or physical cleanup methods. The key enzyme families include laccases (which degrade dyes and aromatic compounds), hydrolases (which break down plastics, insecticides, and food processing waste), and dehalogenases (which strip chlorine atoms from toxic chlorinated compounds like PCBs and TCE).
Bacteria from genera like Pseudomonas, Rhodococcus, and Mycobacterium produce enzymes that degrade pesticides and hydrocarbons under oxygen-rich conditions. In oxygen-poor environments, anaerobic bacteria handle polychlorinated biphenyls and chlorinated solvents. Specific hydrolases from soil bacteria have been successfully used to neutralize common insecticides like carbofuran and parathion. Even microplastic degradation is on the table, with hydrolytic enzymes like cutinase showing the ability to break down certain plastic polymers.